Neurology® Podcast cover image

CRISPR-Cas9 for TTR Amyloidosis; Osmotic Demyelination Syndrome

Neurology® Podcast

00:00

A New Treatment for Alzheimer's Disease

The study has essentially established is that one can deliver a crisper casnine therapeutic at least safely, certainly in a short term. The real challenge over the next five, ten years is going to be delivery, delivery. And i think what we're going to need is the technology to deliver these crispacas, nine therapeutics to a wide range of cells if we want this to really revolutionize medicine.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app